Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases

The current treatment of autoimmune and chronic inflammatory diseases entails systemic immune suppression, which is associated with increased susceptibility to infections. To restore immune tolerance and reduce systemic side effects, a targeted approach using tolerogenic dendritic cells (tolDCs) is...

Descripción completa

Detalles Bibliográficos
Autores principales: ter Braake, Daniëlle, Benne, Naomi, Lau, Chun Yin Jerry, Mastrobattista, Enrico, Broere, Femke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620283/
https://www.ncbi.nlm.nih.gov/pubmed/34834364
http://dx.doi.org/10.3390/pharmaceutics13111949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620283/
https://www.ncbi.nlm.nih.gov/pubmed/34834364
http://dx.doi.org/10.3390/pharmaceutics13111949

Ejemplares similares